MMP-24-M (Recombinant)

Recombinant Protein · expressed in HEK293
Citation tracking pending
Recombinant human Matrix metalloproteinase-24 (MT5-MMP; UniProt Q9Y5R2), expressed in HEK293 cells. Suitable for enzymatic activity assays, inhibitor profiling, and antibody validation studies.
Expression system
HEK293
Cat. #
REC-MMP24M

In stock

SKU
REC-MMP24M
$498.00

Target Overview

MMP-24 (Matrix metalloproteinase-24; also known as MT5-MMP or MTMMP5) is a membrane-anchored zinc-dependent endopeptidase belonging to the membrane-type MMP (MT-MMP) subfamily. It is encoded by the MMP24 gene and catalogued under UniProt accession Q9Y5R2, with a full-length sequence of 645 amino acids. As a cell-surface protease, MMP-24 is localised to the plasma membrane and can be distinguished from secreted MMPs by its transmembrane domain, which tethers it to the pericellular environment and directs its proteolytic activity toward cell-proximal substrates. This recombinant human MMP-24 (SKU: REC-MMP24M) is produced in HEK293 cells, an expression system that supports the mammalian post-translational modifications — including glycosylation and disulfide bond formation — relevant to structural integrity and catalytic activity of MT-MMPs. HEK293-derived material is well-suited to functional biochemistry where native folding is a priority. In the laboratory, this reagent is used primarily in three contexts. First, for enzymatic activity assays: MMP-24 can cleave N-cadherin (CDH2) and activate pro-gelatinase A (MMP-2), and fluorogenic or chromogenic substrate assays can be configured to monitor these activities directly. Second, for inhibitor profiling: the recombinant enzyme serves as a defined target for IC₅₀ determination of small-molecule or peptidic MMP inhibitors, including structure-guided candidates described in recent published work. Third, for antibody validation: researchers requiring a positive control for Western blot or IHC validation of anti-MMP24 antibodies can use this recombinant alongside the matched Triple Point Biologics antibody (RP-MMP24M), which the product page cross-links to directly. The protein is also reported to have proteoglycanase activity against dermatan sulfate and chondroitin sulfate proteoglycans, and partial fibronectin-cleaving activity, offering additional substrate-based assay configurations for researchers studying extracellular matrix remodelling.

Background

MMP-24 is a membrane-type matrix metalloproteinase with a documented role in nociception, neural stem cell biology, and extracellular matrix remodelling. At the molecular level, its best-characterised substrates include N-cadherin (CDH2) and pro-MMP-2 (pro-gelatinase A). Shedding or cleavage of CDH2 by MMP-24 has been linked to two distinct biological contexts: regulation of nociceptive neurite–mast cell interactions contributing to peripheral thermal pain signalling and inflammatory hyperalgesia, and modulation of neural stem cell quiescence in the adult subependymal zone, where CDH2-mediated anchorage to ependymocytes governs stem cell activation state. A role in axonal growth has also been proposed, consistent with its expression in neural tissues. Beyond the nervous system, MMP-24 has been studied as a research target in the context of liver pathology. Farzaneh et al. (2024, Rep Biochem Mol Biol) examined the activity of MMP-17 and MMP-24 in hepatocytes of mice exposed to the hepatotoxin thioacetamide, demonstrating measurable modulation of MMP-24 enzymatic activity under conditions of hepatic injury and exploring curcumin as a pharmacological probe in that model. This published work illustrates a pattern common across the MMP literature: recombinant MMP-24 used as a reference standard to benchmark activity measurements derived from tissue or cell lysates. On the structural and pharmacological side, MMP-24 has attracted interest as a drug target for pain-related indications. Magniez et al. (2026, ACS Med Chem Lett) reported the structure-guided discovery of a nonpeptidic MT5-MMP inhibitor — work that depends on access to well-characterised, active recombinant MT5-MMP protein for inhibitor binding and IC₅₀ assays. The availability of a HEK293-expressed, catalytically competent MMP-24 reagent is a practical prerequisite for this class of study. MMP-24 is also catalogued in genome-wide and candidate-gene association studies of musculoskeletal traits, reflecting its matrix-remodelling role in connective tissues, though in vitro enzymatic characterisation of its specific contribution in those contexts remains an active research area. Researchers validating anti-MMP24 antibodies for Western blot or IHC experiments — including TPB's own matched antibody RP-MMP24M — routinely include recombinant MMP-24 as a defined-quantity positive control, enabling unambiguous band identification and titre assessment without dependence on variable endogenous expression levels in cell lines.

Applications

  • Fluorogenic peptide substrate cleavage assay to measure MMP-24 catalytic activity (e.g., using MCA/Dnp-quenched peptide substrates)
  • Pro-gelatinase A (pro-MMP-2) activation assay: monitoring conversion of pro-MMP-2 to active MMP-2 by zymography or fluorescence
  • Small-molecule inhibitor IC50 determination against recombinant MT5-MMP in a competitive or direct binding format
  • N-cadherin (CDH2) ectodomain cleavage assay to characterise MMP-24 substrate specificity
  • Proteoglycan (dermatan sulfate / chondroitin sulfate) degradation assay to profile glycosaminoglycan-cleaving activity
  • Western blot positive control for anti-MMP24 antibody validation, paired with matched antibody RP-MMP24M
  • Immunohistochemistry antibody validation standard: recombinant protein spiked into tissue lysate as a defined positive control
  • SPR or bio-layer interferometry binding assay to characterise inhibitor or substrate binding kinetics to the MMP-24 catalytic domain

References

  1. Magniez A et al. Structure-Guided Discovery of a Nonpeptidic MT5-MMP Inhibitor. ACS Med Chem Lett. 2026. doi:10.1021/acsmedchemlett.6c00219 PMID: 42305194
  2. Farzaneh S et al. The Effect of Curcumin on the Activity of MMP-17 and MMP-24 in Hepatocytes of Mice Exposed to Thioacetamide. Rep Biochem Mol Biol. 2024. doi:10.61186/rbmb.13.3.329 PMID: 40330566
  3. Yu J et al. The m5C reader protein Ybx1 promotes axon growth by regulating local translation in axons. Development. 2024. doi:10.1242/dev.202781 PMID: 39611865
  4. Harsanyi S et al. Exploratory Analysis of Candidate Gene Variants in Developmental Dysplasia of the Hip: Evidence for the Role of GDF5 rs143384. Genes (Basel). 2026. doi:10.3390/genes17020129 PMID: 41751511
  5. Umesh A et al. Genetic Variants Related to TGF-β Signaling Pathway Modulate Risk of Meniscus Injury: A Multiancestry Genome-wide Association Study. Clin Orthop Relat Res. 2026. doi:10.1097/CORR.0000000000003679 PMID: 40971882

Additional Specifications

Storage Buffer 50 mM Tris-HCl pH 7.5, 150 mM NaCl, 5 mM CaCl₂, 10% glycerol
Endotoxin Level <0.1 EU/µg by LAL
Purity (%) >90% by SDS-PAGE
Expression System HEK293
Subcellular Localization Secreted; Extracellular matrix

Frequently Asked Questions

What molecular weight band does recombinant MMP-24-M run at on SDS-PAGE or Western blot?

The full-length MMP-24 sequence is 645 amino acids (UniProt Q9Y5R2), predicting an unmodified MW of ~71 kDa. However, because REC-MMP24M is expressed in HEK293 cells, N-linked glycosylation adds mass, and the apparent MW on reducing SDS-PAGE typically migrates closer to 75–80 kDa. If you are using our matched antibody RP-MMP24M for Western blot, expect your positive control band in that 75–80 kDa range. Under non-reducing conditions, intermolecular disulfide artifacts can shift the apparent band further — use fresh β-mercaptoethanol or DTT to confirm.

What processing or activation state is recombinant MMP-24-M supplied in — zymogen or active form?

REC-MMP24M is supplied as the active enzyme, not the latent zymogen. The prodomain has been removed during production, so the catalytic domain is accessible without additional activation steps such as APMA treatment. As a membrane-type MMP, MMP-24 is naturally processed at the cell surface; this recombinant reflects that processed, active state. If your assay requires defined latency controls alongside active enzyme, we recommend preparing a separate APMA-treated sample from a zymogen source rather than using this material for that purpose.

What substrates does MMP-24 cleave and which fluorogenic peptide substrate works best for activity assays?

MMP-24 cleaves components of the extracellular matrix including aggrecan, fibronectin, and gelatin, and has been shown to shed cell-surface proteoglycans. For fluorogenic activity assays, the generic MMP substrate Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH₂ (also sold as MMP FRET Substrate I) provides a reliable signal with MT-MMPs at excitation/emission ~320/405 nm. As a starting point, use 10 µM substrate with 0.5–2 nM REC-MMP24M in assay buffer (50 mM Tris-HCl pH 7.5, 150 mM NaCl, 5 mM CaCl₂, 0.05% Brij-35) at 37°C. Validate linearity across your concentration range before comparing inhibitor IC₅₀ values.

What buffer conditions are optimal for MMP-24-M enzymatic activity assays and does calcium matter?

The storage buffer for REC-MMP24M is 50 mM Tris-HCl pH 7.5, 150 mM NaCl, 10% glycerol, 5 mM CaCl₂. Calcium is essential — MMP-24, like all MMPs, requires Ca²⁺ for structural stability of the catalytic domain, and chelation by EDTA or EGTA will abolish activity. For activity assays, dilute into assay buffer matching the storage buffer composition but omitting glycerol and adding 0.05% Brij-35 to reduce surface adsorption. Maintain pH between 7.0 and 7.5; activity drops measurably below pH 6.8. Zinc supplementation (1–10 µM ZnCl₂) can improve signal consistency in extended incubations.

What starting concentration of recombinant MMP-24-M should I use for an inhibitor IC50 assay?

For IC₅₀ determination, enzyme concentration should be well below the substrate Km to satisfy tight-binding assumptions and avoid substrate depletion artifacts. A working range of 0.5–2 nM REC-MMP24M with 10 µM fluorogenic substrate is appropriate as an initial titration point. Confirm that RFU increase is linear over your assay window (typically 30–60 min at 37°C) before adding inhibitor. At higher enzyme loads (>5 nM), substrate depletion within the assay window can compress apparent IC₅₀ values. Include a broad-spectrum MMP inhibitor such as GM6001 (1 µM) as a positive inhibition control in every plate.

Can I use REC-MMP24M as a positive control for Western blot with the matched antibody RP-MMP24M?

Yes — that is the primary design intent of the pairing. RP-MMP24M (see /anti-mmp-24m-rabbit-polyclonal-antibody) is a rabbit polyclonal antibody validated for Western blot against this recombinant, so the two are guaranteed compatible. Load 20–50 ng of REC-MMP24M per lane on a standard 10% SDS-PAGE gel under reducing conditions. This produces a clean band at ~75–80 kDa that serves both as a size marker for endogenous MMP-24 in your cell lysates and as a sensitivity reference for antibody dilution optimization. Run alongside your lysate to confirm band co-migration before committing to a full experimental set.

How much recombinant MMP-24-M should I load for Western blot positive control and what antibody dilution is recommended?

Load 20–50 ng of REC-MMP24M per lane for a strong, unambiguous positive control band. For the matched antibody RP-MMP24M, start at a 1:1000 dilution in 5% non-fat milk/TBST for primary incubation (overnight, 4°C); titrate to 1:2000 if background is high in your specific membrane system. The recombinant runs at ~75–80 kDa under reducing conditions. If you are loading total cell lysate alongside, 10–20 ng of recombinant is usually sufficient to distinguish the spiked band from endogenous signal without overwhelming the lane. Confirm with Ponceau staining to verify equal transfer before immunodetection.

How should I handle, dilute, and store REC-MMP24M to preserve enzymatic activity over time?

REC-MMP24M is supplied in 50 mM Tris-HCl pH 7.5, 150 mM NaCl, 10% glycerol, 5 mM CaCl₂ and is stored at −20°C in single-use aliquots. Repeated freeze-thaw cycles measurably reduce specific activity — do not refreeze working aliquots. When diluting to low concentrations (<10 nM) for activity assays, use carrier protein (0.1% BSA, protease-free) in your dilution buffer to prevent adsorption losses to plastic surfaces. On ice, the enzyme is stable for 4–6 hours; avoid prolonged incubation at 37°C without substrate present. Purity is >90% by SDS-PAGE and endotoxin is <0.1 EU/µg, so no additional clean-up steps are needed before functional assays.

Validation imagery coming soon

Western blot validation figures for REC-MMP24M will be published here as they are produced in-house.

If you would like to see existing validation data for this antibody before publication, request a sample copy.

  • Product Datasheet

    Full specifications, immunogen, validation, and recommended protocols.

    Request PDF →
  • Certificate of Analysis (COA)

    Lot-specific QC report. Available on request for any catalog lot.

    Request COA →
  • Safety Data Sheet (SDS)

    Handling, storage, and disposal guidance per regulatory standards.

    Request SDS →